Skip to main content
SpringerLink
Log in

Lonidamine: Angelini's anticancer agent has been approved for marketing in Italy

  • Newsletter Article
  • Published:
InPharma

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lonidamine: Angelini's anticancer agent has been approved for marketing in Italy. Inpharma Wkly. 583, 19 (1987). https://doi.org/10.1007/BF03291319

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03291319

Keywords

Search

Navigation